The tariff classification of a molded plastic case from Canada
No Headquarters ruling in this index revokes or modifies this ruling. That is not confirmation that it is still in effect: this index does not hold every Headquarters ruling. Confirm its current status with CBP before relying on it (ruling on CBP CROSS). Text last read from CBP on Nov 21, 2026.
Key passages, quoted from the ruling
- The applicable subheading for the case will be 4202.99.9000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for other containers and cases, other, other, other.
- The general rate of duty will be 20 percent ad valorem.
Ruling text
In your letter dated August 22, 2026, you requested a tariff classification ruling. You have submitted product information and photographs for our review. The CortoPod ACT case is designed for the daily transport, organization, identification, and accessibility of the core components of an emergency hydrocortisone injection kit.
Its dimensions, internal geometry, fitted compartments, removable holders, retrieval cutouts, component-specific covers, and medical labeling are specifically designed around that use and limit its utility as a general-purpose storage container. It is constructed of molded plastic and the interior is fitted to contain the hydrocortisone.
The applicable subheading for the case will be 4202.99.9000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for other containers and cases, other, other, other. The general rate of duty will be 20 percent ad valorem.
In your submission you requested consideration of a secondary classification under 9817.00.96, HTSUS, which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
Subheading 9817.00.96, HTSUS, covers: “[a]rticles specially designed or adapted for the use or benefit of the blind or other physically or mentally handicapped persons; parts and accessories (except parts and accessories of braces and artificial limb prosthetics) that are specially designed or adapted for use in the foregoing articles: [o]ther.” The term “blind or other physically or mentally handicapped persons” includes “any person suffering from a permanent or chronic physical or mental impairment which substantially limits one or more major life activities, such as caring for one’s self, performing manual tasks, walking, seeing, hearing, speaking, breathing, learning, or working.” U.S. Note 4(a), Subchapter XVII, Chapter 98, HTSUS.
Subheading 9817.00.96, HTSUS, excludes “(i) articles for acute or transient disability; (ii) spectacles, dentures, and cosmetic articles for individuals not substantially disabled; (iii) therapeutic and diagnostic articles; or, (iv) medicine or drugs.” As indicated in U.S. Note 4(b)(iv), Subchapter XVII, Chapter 98, HTSUS, medicines and drugs, such as hydrocortisone, do not qualify for tariff treatment under subheading 9817.00.96.
As such, the cases for such medicines and drugs cannot be afforded special tariff treatment. The subject case is not eligible for secondary tariff treatment under subheading 9817.00.96, HTSUS. The duties cited above are current as of this ruling’s issuance. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/.
This ruling does not address the applicability of any additional duties, taxes, fees, exactions and/or other charges, which may apply to the goods discussed herein. This includes, but is not limited to, tariffs and other duties as provided for in Subchapter III to Chapter 99, HTSUS.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N364486).